These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

68 related items for PubMed ID: 6974263

  • 1. Characteristics of xenograft. II. Cytostatic effector mechanism for xenograft rejection.
    Nomoto K, Terasaka R, Himeno K, Shiraishi M.
    Jpn J Exp Med; 1981 Apr; 51(2):81-7. PubMed ID: 6974263
    [Abstract] [Full Text] [Related]

  • 2. Characteristics of xenograft rejection. I. Augmented cytotoxicity of peritoneal T cells after intraperitoneal injection of booster antigen and/or proteose peptone.
    Terasaka R, Himeno K, Shiraishi M, Nomoto K.
    Jpn J Exp Med; 1981 Apr; 51(2):75-80. PubMed ID: 6974262
    [Abstract] [Full Text] [Related]

  • 3. Differing contribution of various effector cells in the elimination of syngeneic or allogeneic cells.
    Matsumoto T, Himeno K, Mitani M, Mori K, Miake S, Nomoto K.
    J Clin Lab Immunol; 1986 Feb; 19(2):83-9. PubMed ID: 3083105
    [Abstract] [Full Text] [Related]

  • 4. Relationships among differentiated T-cell subpopulations. V. T-cell dependent mechanism of xenograft rejection and its radioresistant nature.
    Terasaka R, Nomoto K, Himeno K.
    Immunology; 1979 Dec; 38(4):773-9. PubMed ID: 316419
    [Abstract] [Full Text] [Related]

  • 5. Rejection of syngeneic tumor cells by the interaction of Lyt-1+ T lymphocytes and macrophages.
    Mitani M, Matsumoto T, Mori K, Miake S, Himeno K, Nomoto K.
    J Clin Lab Immunol; 1985 Oct; 18(2):97-101. PubMed ID: 3935795
    [Abstract] [Full Text] [Related]

  • 6. Effector mechanism of tumor immunity in murine plasmacytoma.
    Chen YH, Anderson AB.
    Cancer Res; 1988 Mar 15; 48(6):1398-403. PubMed ID: 3257896
    [Abstract] [Full Text] [Related]

  • 7. Virus-dependent cytostatic activity to mammary tumor cells of lymphocytes from normal mice.
    Gillette RW, Lowery LT.
    Cancer Res; 1976 Nov 15; 36(11 Pt 1):4008-14. PubMed ID: 184922
    [Abstract] [Full Text] [Related]

  • 8. Selective blocking of T cell-mediated in vitro cytotoxicity to a xenogeneic tumour by anti-immunoglobulin sera.
    Newlands ES, Hay FC, Roitt IM.
    Clin Exp Immunol; 1978 Feb 15; 31(2):189-96. PubMed ID: 306324
    [Abstract] [Full Text] [Related]

  • 9. Evidence for cytostatic T cell activity in the effector mechanism against syngeneic TMT mammary tumor cells in mice.
    Kurata S, Tsuchiya T, Norimura T, Yamashita U.
    J Immunol; 1983 Jan 15; 130(1):496-500. PubMed ID: 6600195
    [Abstract] [Full Text] [Related]

  • 10. Allograft cytotoxicity. Two populations of effector cell detectable by cytolytic and cytostatic assays in vitro.
    Jones B, Jones TC, Roitt IM.
    Immunology; 1977 Apr 15; 32(4):591-9. PubMed ID: 415967
    [Abstract] [Full Text] [Related]

  • 11. Secondary cytotoxic tumor immune response induced in vitro.
    Röllinghoff M.
    J Immunol; 1974 May 15; 112(5):1718-25. PubMed ID: 4544796
    [No Abstract] [Full Text] [Related]

  • 12. Inhibition of skin xenograft rejection by depleting T-cell receptor alpha beta-bearing cells without T-cell receptor gamma delta-bearing cells or natural killer cells by monoclonal antibody.
    Nishimura Y, Eto M, Maeda T, Hiromatsu K, Kobayashi N, Nomoto K, Kong YY, Nomoto K.
    Immunology; 1994 Oct 15; 83(2):196-204. PubMed ID: 7835935
    [Abstract] [Full Text] [Related]

  • 13. The activity of inducible nitric oxide synthase in rejected skin xenografts is selectively inhibited by a factor produced by grafted cells.
    Holán V, Pindjáková J, Zajícová A, Krulová M, Zelezná B, Matousek P, Svoboda P.
    Xenotransplantation; 2005 May 15; 12(3):227-34. PubMed ID: 15807773
    [Abstract] [Full Text] [Related]

  • 14. Tumor growth inhibitory and natural suppressor activities of murine bone marrow cells: a comparative study.
    Seledtsov VI, Taraban VY, Seledtsova GV, Samarin DM, Avdeev IV, Senyukov VV, Kozlov VA.
    Cell Immunol; 1997 Nov 25; 182(1):12-9. PubMed ID: 9427805
    [Abstract] [Full Text] [Related]

  • 15. Humoral and cellular immunopathology of hepatic and cardiac hamster-into-rat xenograft rejection. Marked stimulation of IgM++bright/IgD+dull splenic B cells.
    Langer A, Valdivia LA, Murase N, Woo J, Celli S, Fung JJ, Starzl TE, Demetris AJ.
    Am J Pathol; 1993 Jul 25; 143(1):85-98. PubMed ID: 7686346
    [Abstract] [Full Text] [Related]

  • 16. Role of cytostasis in antitumor immunity against syngeneic X5563 plasmocytoma: comparative study of cytostasis and cytolysis using variant tumors and neonatally thymectomized mice.
    Mitani M, Himeno K, Mori K, Nomoto K.
    J Clin Lab Immunol; 1989 May 25; 29(1):45-52. PubMed ID: 2628584
    [Abstract] [Full Text] [Related]

  • 17. Tumour cell destruction by macrophages from conventional animals.
    Holán V, Hasek M, Bubeník J.
    Folia Biol (Praha); 1975 May 25; 21(1):43-9. PubMed ID: 164392
    [Abstract] [Full Text] [Related]

  • 18. Simian virus 40 large-T-antigen-specific rejection of mKSA tumor cells in BALB/c mice is critically dependent on both strictly tumor-associated, tumor-specific CD8(+) cytotoxic T lymphocytes and CD4(+) T helper cells.
    Utermöhlen O, Schulze-Garg C, Warnecke G, Gugel R, Löhler J, Deppert W.
    J Virol; 2001 Nov 25; 75(22):10593-602. PubMed ID: 11602701
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Development of highly sensitive Bicistronic vector based non-radioactive antigen-specific cytotoxicity assay.
    Gupta P, Tayal R, Durgapal H, Rath S, Acharya SK, Panda SK.
    J Immunol Methods; 2009 Sep 30; 349(1-2):28-37. PubMed ID: 19682994
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.